ASA 10-6, Issue No. 141, December 31, 2010

ASA, CBMTS and JMedCBR: Continuing Professionals in CBW History

          Barbara Saunders-Price (PhD), together with Col. Richard M. Price (USAF retired), began Applied Science and Analysis, ASA Inc., in 1983, when they saw a continuing need for communication between various organizations in the US Department of Defense, DoD, and worldwide. ASA's first contracts were to provide industry liaison with US military laboratories researching defense issues in chemical and biological defense.

          In 1969, President Nixon said the US would not use CW and renounced the use of BW. Most CBW research ended, including much of the chemical and biological defense research, development, testing and evaluation. In 1972, the US signed the Biological and Toxin Weapon Convention (and ratified it in 1975). Future biological weapons research was confined to defensive measures such as immunization, detection and safety. Research in chemical weapons stopped, including most chemical defense research. The entire CB defense budget for the US was less than $30 Million. In 1973, the US Army Chemical Corps was disbanded. By 1978, with continued intelligence about global activities in CBW, the US Joint Chiefs declared that the US was unprepared for chemical and biological defense. In 1979 the release of anthrax in Sverdlosk occurred. Separately, in 1979 the US Congress passed a law to fund and add collective protection on communications vans and shelters by 1991.

          Before the Army could buy and add collective protection, they had to know exactly how many vans and shelters were going to get the protection. This was Richard M. Price's first project as a civilian working for NASA's National Space Technology Laboratories' Engineering Laboratory in 1980. In 1980, the US CB defense budget was approximately $50 Million. Fortunately for the CB defense community, he brought his exceptional organization and communications skills, and international perspective, to work in an area that badly needed them.


Full Article

Jiri Bajgar, MD, PhD, and other numerous titles, has contributed to the ASA Newsletter and CBMTS over the many years we have known him. We are proud to present the following article that summarizes much of his research in oxime reactivators for nerve agents and OPs. His insight helps all of us understand the many facets of nerve agent poisoning and possible treatments.

Organophosphates/Nerve Agents Poisoning and Their Treatment: A Summary in Schematics

Jiri Bajgar

Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic,


          The actions of organophosphates/nerve agents (toxicodynamics) are described and summarized. Based on these toxicodynamics, the principles for therapeutic and prophylactic countermeasures are examined, including some examples of unsolved questions and possible approach to their elucidation. The primary intent of this article is to summarize the Czech approach to nerve agent treatment and the structures of the nerve agents, their major effects and the major oximes for in one easy to read article with very limited references.

Full Article

an inside look at ASA 10-6

The Professional Library

CBMTS Industry VII

Flooding of the Pontine Marshes in WWII


AUTHOR INDEX: 1987 through 2010
International Laboratory/NBC Schools Series

For the Professional in Government and Industry with an interest in Nuclear, Biological and Chemical Defense, Disarmament and Verification; Emergency and Disaster Medical Planning; Industrial Health and Safety; and Environmental Protection

copyright©2010, ASA Inc. All rights reserved.